These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26714701)

  • 1. Quantifying CD4/CCR5 Usage Efficiency of HIV-1 Env Using the Affinofile System.
    Webb NE; Lee B
    Methods Mol Biol; 2016; 1354():3-20. PubMed ID: 26714701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.
    Chikere K; Webb NE; Chou T; Borm K; Sterjovski J; Gorry PR; Lee B
    Retrovirology; 2014 Jun; 11():48. PubMed ID: 24957778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.
    Chikere K; Chou T; Gorry PR; Lee B
    Virology; 2013 Jan; 435(1):81-91. PubMed ID: 23217618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779.
    Gharu L; Ringe R; Bhattacharya J
    Virus Res; 2011 Jun; 158(1-2):216-24. PubMed ID: 21524671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
    Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
    J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the Sensitivity of HIV-1 Viral Entry to Receptor and Coreceptor Expression.
    Mistry B; D'Orsogna MR; Webb NE; Lee B; Chou T
    J Phys Chem B; 2016 Jul; 120(26):6189-99. PubMed ID: 27137677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.
    Hongjaisee S; Braibant M; Barin F; Ngo-Giang-Huong N; Sirirungsi W; Samleerat T
    AIDS Res Hum Retroviruses; 2017 Sep; 33(9):946-951. PubMed ID: 28497977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of HIV entry.
    Wilen CB; Tilton JC; Doms RW
    Adv Exp Med Biol; 2012; 726():223-42. PubMed ID: 22297516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.
    Santos-Costa Q; Lopes MM; Calado M; Azevedo-Pereira JM
    Retrovirology; 2014 Nov; 11():99. PubMed ID: 25421818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.
    Johnston SH; Lobritz MA; Nguyen S; Lassen K; Delair S; Posta F; Bryson YJ; Arts EJ; Chou T; Lee B
    J Virol; 2009 Nov; 83(21):11016-26. PubMed ID: 19692480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo.
    Tsao LC; Guo H; Jeffrey J; Hoxie JA; Su L
    Retrovirology; 2016 Mar; 13():22. PubMed ID: 27026376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins.
    Dobrowsky TM; Rabi SA; Nedellec R; Daniels BR; Mullins JI; Mosier DE; Siliciano RF; Wirtz D
    Sci Rep; 2013 Oct; 3():3014. PubMed ID: 24145278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
    Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
    J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor.
    Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE
    Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
    Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
    Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.